The grass is the same colour, part II: prescription drug woes on both sides of the US-Canada border

Health Affairs

13 February 2020 - Which industrialised nation with a fractured health care system and a divided government is having a high-stakes political debate over the cost and coverage of prescription drugs? 

Many Americans—and congressional observers—might be surprised that the United States is not alone in debating the cost of prescription drugs and policies to make them more accessible. Indeed, Canada—a country often held up by liberals in the US as an aspirational model for our health care system and seen as part of a potential remedy for our own drug pricing woes—is having a similar debate. 

As discussed in my prior blog posts based on a fellowship experience in Australia and a summit of health care stakeholders in the US and Canada, we can learn from other countries’ health care policies despite structural differences.

Read Health Affairs Blog

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Canada , Affordability